Trucept, Inc.
TREP
$0.043
$0.000.00%
| Weiss Ratings | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C | |||
| Rating Factors | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.30 | |||
| Price History | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.42% | |||
| 30-Day Total Return | -28.33% | |||
| 60-Day Total Return | 22.86% | |||
| 90-Day Total Return | -4.44% | |||
| Year to Date Total Return | 38.71% | |||
| 1-Year Total Return | 17.17% | |||
| 2-Year Total Return | -2.27% | |||
| 3-Year Total Return | -50.29% | |||
| 5-Year Total Return | 86.96% | |||
| 52-Week High % Change | -44.34% | |||
| 52-Week Low % Change | 65.38% | |||
| Price | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.08 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Apr 23, 2024 | |||
| 52-Week High Price (Date) | Feb 13, 2025 | |||
| Valuation | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.41M | |||
| Enterprise Value | -552.97K | |||
| Price/Earnings (TTM) | 1.47 | |||
| Earnings Per Share (TTM) | 0.03 | |||
| Earnings Per Share Growth | -55.35% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.11 | |||
| Price/Book (Q) | 0.11 | |||
| Enterprise Value/Revenue (TTM) | -0.03 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -0.41 | |||
| Enterprise Value/EBIT | -0.34 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.10M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858-923-4225 | |||
| Address | 600 La Terraza Blvd. Escondido, CA 92025 | |||
| Website | trucept.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.45% | |||
| Profit Margin | 7.45% | |||
| Management Effectiveness | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.90% | |||
| Return on Equity | 7.71% | |||
| Income Statement | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 21.98M | |||
| Total Revenue (TTM) | 21.98M | |||
| Revenue Per Share | $0.39 | |||
| Gross Profit (TTM) | 14.88M | |||
| EBITDA (TTM) | 1.36M | |||
| EBIT (TTM) | 1.64M | |||
| Net Income (TTM) | 1.64M | |||
| Net Income Avl. to Common (TTM) | 1.64M | |||
| Total Revenue Growth (Q YOY) | 32.92% | |||
| Earnings Growth (Q YOY) | 14.91% | |||
| EPS Diluted (TTM) | 0.03 | |||
| EPS Diluted Growth (Q YOY) | 13.95% | |||
| Balance Sheet | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 196.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 7.04M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 22.07M | |||
| Current Ratio (Q) | 1.260 | |||
| Book Value Per Share (Q) | $0.39 | |||
| Total Assets (Q) | 27.78M | |||
| Total Current Liabilities (Q) | 5.58M | |||
| Total Debt (Q) | 167.40K | |||
| Total Liabilities (Q) | 5.71M | |||
| Total Common Equity (Q) | 22.07M | |||
| Cash Flow | TREP - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -628.60K | |||
| Cash from Financing (TTM) | -282.40K | |||
| Net Change in Cash (TTM) | 155.40K | |||
| Levered Free Cash Flow (TTM) | -2.62M | |||
| Cash from Operations (TTM) | 1.07M | |||
